Frailty and arteriovenous fistula patency in elderly hemodialysis patients: a retrospective cohort study.
Polyana Bezerra Mendonça, Rodrigo Bezerra, Flávio Teles and 7 others
PMID 40905666WHAT IT FOUND
Frail elderly hemodialysis patients required significantly more surgical interventions to keep their fistulas working.
They also had higher mortality and longer delays before first use. These findings suggest fistula creation may offer fewer short-term benefits for this group.
Key findings
01Frail patients had a higher prevalence of assisted patency (requiring surgery or angioplasty) compared to non-frail patients.
02Frailty was significantly associated with higher mortality, with 61.5% of deaths occurring in frail patients versus 25.4% in survivors.
03Frail patients experienced longer delays before starting arteriovenous fistula use and required more complex surgical procedures.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study design is retrospective, relying on medical records which may introduce selection and information bias. The sample size was small (89 patients), limiting the generalizability of the findings. Participants were recruited from a specific geographic region (Brazil), which may not reflect other healthcare systems or populations. The study did not randomize patients, so unmeasured confounding factors could influence the association between frailty and AVF outcomes.
Declared interests
The authors declared no conflicts of interest. The study was approved by the Ethics Committee of the Oswaldo Cruz University Hospital.
The easy way to misread this
Do not conclude that AVF creation is universally contraindicated for frail elderly patients. The study shows increased burden and mortality associations, but it is an observational cohort with a small sample size. Decisions should be individualized based on the patient's specific clinical context and goals, not solely on a frailty score.